Product Information
KIONEX 15 GM/60 ML SUSPENSION is a brand (anda) product labeled by ANI Pharmaceuticals, Inc., priced at $0.3056 per ML under NDC 62559035601. Its NADAC has been published 64 times since Jun 12, 2024.
FDA first approved this application on Sep 17, 2007. Its Orange Book therapeutic-equivalence code is AA.
Strength
15 g/60mL
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559035601
Classification
Brand (ANDA)
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SODIUM POLYSTYRENE SULFONATEApproval Type
Generic (ANDA)
FDA Application
ANDA040028FDA Approved
9/17/2007
TE Code
AA
On Market Since
5/3/2024
Price Statistics
The NADAC for KIONEX 15 GM/60 ML SUSPENSION has been published 64 times since Jun 12, 2024, and over the history we have for it it has declined 24.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3056 per ML |
|---|---|
| All-time high | $0.4089 (Jun 19, 2024) |
| All-time low | $0.3016 (Jul 22, 2026) |
| 52-week high | $0.3377 |
| 52-week low | $0.3016 |
| Median price | $0.3284 |
| Average price | $0.3276 |
| Largest weekly change | -17.1% (Jun 18, 2025) |
| Weeks tracked | 64 |
| Tracking since | Jun 12, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Sodium Polystyrene Sulfonate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sodium Polystyrene Sulfonate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of KIONEX 15 GM/60 ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for KIONEX 15 GM/60 ML SUSPENSION, manufactured by ANI Pharmaceuticals, Inc., is $0.3056 per ML (NDC 62559035601), effective Sep 30, 2026.
How has the price of KIONEX 15 GM/60 ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for KIONEX 15 GM/60 ML SUSPENSION has declined 24.6%. It has been tracked across 64 weekly CMS publications since Jun 12, 2024.
What are the highest and lowest recorded NADAC prices for KIONEX 15 GM/60 ML SUSPENSION?
Since Jun 12, 2024, the NADAC for KIONEX 15 GM/60 ML SUSPENSION has ranged from a low of $0.3016 (Jul 22, 2026) to a high of $0.4089 (Jun 19, 2024), with a median of $0.3284 per ML.
Are there cheaper alternatives to KIONEX 15 GM/60 ML SUSPENSION?
No other NADAC-published product currently shares the active ingredient and strength of KIONEX 15 GM/60 ML SUSPENSION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures KIONEX 15 GM/60 ML SUSPENSION?
KIONEX 15 GM/60 ML SUSPENSION (NDC 62559035601) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a brand (anda) product.